PA
RVMD icon

Profund Advisors’s Revolution Medicines RVMD Stock Holding History

Profund Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Sell
19,741
-7,188
-27% -$726K 0.07% 219
2025
Q4 		$2.14M Sell
26,929
-10,150
-27% -$666K 0.07% 201
2025
Q3 		$1.73M Buy
37,079
+6,585
+22% +$258K 0.06% 219
2025
Q2 		$1.12M Sell
30,494
-5,015
-14% -$193K 0.04% 278
2025
Q1 		$1.26M Buy
35,509
+30
+0.1% +$1.22K 0.05% 254
2024
Q4 		$1.55M Buy
35,479
+544
+2% +$27.5K 0.06% 217
2024
Q3 		$1.58M Sell
34,935
-1,064
-3% -$46.3K 0.06% 234
2024
Q2 		$1.4M Sell
35,999
-10,115
-22% -$378K 0.05% 242
2024
Q1 		$1.49M Sell
46,114
-14,993
-25% -$444K 0.06% 231
2023
Q4 		$1.75M Buy
61,107
+21,711
+55% +$522K 0.08% 198
2023
Q3 		$1.09M Sell
39,396
-20,312
-34% -$602K 0.06% 265
2023
Q2 		$1.6M Sell
59,708
-1,542
-3% -$37.8K 0.09% 187
2023
Q1 		$1.33M Buy
+61,250
New +$1.51M 0.08% 223

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Profund Advisors's RVMD Position: Q1 2026 in Review

Profund Advisors reduced its Revolution Medicines (RVMD) stake by 27% in Q1 2026, selling an estimated $726K and leaving 19,741 shares worth $1.92M. The position accounts for 0.07% of the portfolio, ranked #219.

Profund Advisors first reported a position in RVMD in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.14M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Profund Advisors held 19,741 shares of Revolution Medicines worth $1.92M as of Q1 2026.
  • Profund Advisors sold 7,188 Revolution Medicines shares in Q1 2026, an estimated $726K.
  • Revolution Medicines made up 0.07% of Profund Advisors's portfolio in Q1 2026, its #219 holding.
  • Profund Advisors first reported a position in Revolution Medicines in Q1 2023 and has held it in 13 quarters since.
  • Profund Advisors's Revolution Medicines position peaked at $2.14M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.